Publications in collaboration with researchers from Hospital Universitario La Paz (38)

2023

  1. Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105

  2. Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies

    Expert Review of Hematology, Vol. 16, Núm. 3, pp. 213-226

  3. EAACI Molecular Allergology User's Guide 2.0

    Pediatric Allergy and Immunology, Vol. 34, Núm. S28

2022

  1. Iniciativas para la mejora del manejo de los pacientes con coagulopatías congénitas por parte de farmacia hospitalaria

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 109-115

  2. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

    JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560

2021

  1. Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 5, pp. 268-272

  2. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases

    Frontiers in Immunology, Vol. 12

  3. Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E66-E71

2020

  1. BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis

    FASEB Journal, Vol. 34, Núm. 8, pp. 10531-10546

  2. Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure

    British Journal of Pharmacology, Vol. 177, Núm. 14, pp. 3273-3290

  3. Innate Immune Receptors, Key Actors in Cardiovascular Diseases

    JACC: Basic to Translational Science, Vol. 5, Núm. 7, pp. 735-749

  4. Registry of patients with congenital bleeding disorders and COVID-19 in Madrid

    Haemophilia, Vol. 26, Núm. 5, pp. 773-778

2019

  1. Accelerating recovery from acute hemarthrosis in patients with hemophilia: The role of joint aspiration

    Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 111-119

2018

  1. Deficiency of NOD1 improves the β-adrenergic modulation of Ca2+ handling in a mouse model of heart failure

    Frontiers in Physiology, Vol. 9, Núm. JUN

2017

  1. Identification of new SNPs associated with severe toxicity to capecitabine

    Pharmacological Research, Vol. 120, pp. 133-137

  2. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes

    Biochemical Journal, Vol. 474, Núm. 3, pp. 399-410

  3. Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling

    Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 423-433

  4. Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

    Pharmacogenomics, Vol. 18, Núm. 13, pp. 1215-1223

2016

  1. Cell expansion-dependent inflammatory and metabolic profile of human bone marrow mesenchymal stem cells

    Frontiers in Physiology, Vol. 7, Núm. NOV

  2. Multimodal blood loss prevention approach including intra-articular tranexamic acid in primary total knee arthroplasty for patients with severe haemophilia A

    Haemophilia